BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
HIV infection
,
Leukocyte
,
Acetaminophen
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NY-ESO-1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Bladder cancer
Tuberculosis
Pancreatic cancer
Neuroendocrine tumor
Uterine cancer
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Ions
AR A014418
styrene oxide
benz(a)anthracene
ethyl protocatechuate
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SMG7
TAF1
SP1
LGALS4
KAT5
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Decoding NY-ESO-1 TCR T cells: transcriptomic insights reveal dual mechanisms of tumor targeting in …
PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and…
Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analy…
Simultaneous noninvasive ultrasensitive detection of prostate specific antigen and lncRNA PCA3 using…
Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightf…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expre…
Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1
NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving …
Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally …
Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ